Zepp Health Corporation ZEPP
NYSE
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 43.03% | 46.17% | -3.68% | -28.31% | -48.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.03% | 46.17% | -3.68% | -28.31% | -48.91% |
| Cost of Revenue | 34.93% | 56.15% | -4.40% | -30.61% | -54.10% |
| Gross Profit | 56.94% | 31.36% | -2.43% | -23.99% | -38.78% |
| SG&A Expenses | 37.86% | 6.66% | 18.57% | 16.28% | 15.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.02% | 29.70% | 1.90% | -16.81% | -32.71% |
| Operating Income | 56.69% | 38.17% | -15.99% | -1,309.47% | -1,009.14% |
| Income Before Tax | 61.83% | 30.57% | -33.92% | -1,536.48% | -4,093.67% |
| Income Tax Expenses | -84.76% | 414.89% | 53.63% | 388.84% | -- |
| Earnings from Continuing Operations | 70.27% | 28.64% | -34.01% | -3,100.71% | -5,084.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 268.92% | -70.37% |
| Net Income | 70.25% | 28.58% | -34.31% | -3,058.00% | -4,622.53% |
| EBIT | 56.69% | 38.17% | -15.99% | -1,309.47% | -1,009.14% |
| EBITDA | 64.38% | 38.99% | -22.76% | -392.78% | -412.82% |
| EPS Basic | 69.88% | 26.66% | -35.93% | -2,863.70% | -4,351.30% |
| Normalized Basic EPS | -- | -- | -- | -- | -2,892.47% |
| EPS Diluted | 68.12% | 26.66% | -34.81% | -2,863.70% | -5,228.13% |
| Normalized Diluted EPS | -- | -- | -- | -- | -3,051.14% |
| Average Basic Shares Outstanding | -1.24% | -2.64% | -1.20% | 6.50% | 6.27% |
| Average Diluted Shares Outstanding | -1.23% | -2.63% | -1.19% | 6.50% | 0.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |